July 22nd, 2020
A versatile vessel for next-gen therapeutics
Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
July 22nd, 2020
Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs
October 3rd, 2018
In exploring the action of microvesicles, Quan Lu and colleagues at Harvard Chan School are mapping the next frontier of medical diagnostics and drug delivery
September 27th, 2017
Accelerator-supported research suggests engineered sacs called ARMMs may be uniquely suited to send therapeutics directly to affected areas of the body